Dynamic Response to Probiotics in Context of Alzheimer Disease: a Proof-of-concept Study

NCT ID: NCT05521477 Phase: NA Status: COMPLETED Enrollment: 3 Completion: 2024-02-28

Conditions

Alzheimer Disease

Interventions

SLAB51

Summary

proof-of-concept study to adequately design a larger trial to investigate the effect of supplementation of a probiotic (SLAB51) on AD biomarker.

Primary Outcome

Concentration of plasma AD biomarker, Amyloid

Source

ClinicalTrials.gov